Table 3.
Author, year (reference) | Design | N | Indication | PDFF threshold (%) | Sensitivity | Specificity |
Bohte et al47 | Meta-analysis: 11 studies from 2001 to 2009 | 569 | Potential liver donor/NAFLD/liver resection | N/A | Grade > 0%: 0.82 Grade > 10%: 0.90 Grade > 25%: 0.97 |
Grade > 0%: 0.90 Grade > 10%: 0.95 Grade > 25%: 0.76 |
Idilman et al | Retrospective | 70 | Biopsy-proven NAFLD | Grade ≥ 2: 15% | Grade ≥ 2: 0.93 | Grade ≥ 2: 0.85 |
Tang et al76 | Prospective | 89 | NAFLD | Grade ≥ 1: 6.4 Grade ≥ 2: 17.4 Grade = 3: 22.1 |
Grade ≥ 1: 0.86 Grade ≥ 2: 0.64 Grade = 3: 0.71 |
Grade ≥ 1: 0.83 Grade ≥ 2: 0.96 Grade = 3: 0.92 |
Paige et al39 | Prospective | 61 | Biopsy-proven NAFLD | Grade ≥ 2: 13.45 Grade = 3: 16.83 |
Grade >= 2: 0.85 Grade = 3: 1.00 |
Grade >= 2: 0.96 Grade = 3: 0.81 |
Middleton et al., 201777 | Multicenter RCT | 110 | Paediatric NAFLD clinical trial | Grade ≥ 2: 17.5 Grade = 3: 23.3 |
Grade ≥ 2: 0.74 Grade = 3: 0.60 |
0.90a |
Middleton et al., 201777 | Multicenter RCT | 113 | NASH clinical trial | Grade ≥ 2: 16.3 Grade = 3: 21.7 |
Grade ≥ 2: 0.83 Grade = 3: 0.84 |
0.90a |
N, sample size; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; PDFF, proton-density fat fraction; RCT, randomised controlled trial.
aPDFF threshold was chosen for a target specificity of 0.90.